Læknablaðið - 15.01.1996, Blaðsíða 77

LÆKNABLAÐIÐ 1996; 82
59
experience. In: Khanna R, Nolph KD, Prowant B,
Twardowski ZJ, Oreopoulos DG, eds. Advances in con-
tinuous ambulatory peritoneal dialysis. Toronto: Uni-
versity of Toronto, 1986: 176-81.
12. Cantaluppi A, Scalamogna A, Castelnovo C, Graziani
G. Long-term efficacy of a Y-connector and disinfectant
to prevent peritonitis in continuous ambulatory perito-
neal dialysis. In: Khanna R, Nolph KD, Prowant B,
Twardowski ZJ, Oreopoulos DG, eds. Advances in con-
tinuous ambulatory peritoneal dialysis. Toronto: Uni-
versity of Toronto, 1986: 181-5.
13. Mion C, Slingeneyer A, Canaud B, Mourad G, Chong
C, Béraud JJ, et al. The Benefits and Proper Role of
CAPD. Contr Nephrol 1985 ; 44: 148-62.
14. Lamperi S, Carozzi S. Immunological Defenses in
CAPD. Blood Purif 1989; 7: 126-43.
15. Lamperi S, Carozzi S. Peritonitis Prevention in CAPD
by Intraperitoneal IgG. Contr Nephrol 1989; 70: 325-9.
16. Hamburger RJ, Mattern WD, Schreiber MJ Jr., So-
derblom R, Sorkin M, Zimmerman SW. A Dialysis
Modality Decision Guide Based on the Experience of
Six Dialysis Centers. Dialysis and Transplantation 1990;
19: 66-9.
17. Working Party of the British Society for Antimicrobial
Chemotherapy. Diagnosis and Management of Periton-
itis in Continuous Ambulatory Peritoneal Dialysis. Lan-
cet 1987; i: 845-9.
18. Peterson PK, Matzke G, Keane WF. Current Concepts
in the Management of Peritonitis in Patient Undergoing
Continuous Ambulatory Peritoneal Dialysis. Rev Infect
Dis 1987; 9: 604-12.
19. Kristinsson KG, Spencer RC, Hastings JGM. Clinical
importance of production of slime by coagulase negative
staphylococci in chronic ambulatory peritoneal dialysis.
J Clin Pathoi 1986; 39: 117-8.
20. Verbrugh HA, Keane WF, Hoidal JR, Freiberg MR,
Elliott GR, Peterson PK. Peritoneal macrophages and
opsonins: antibacterial defense in patients undergoing
chronic peritoneal dialysis. J Infect Dis 1983; 147: 1018-
29.
21. Winton MD, Everett ED. Antimicrobial Therapy for
CAPD-Associated Peritonitis. Blood Purif 1989; 7:115-
25.
22. Gokal R, Jakubowski C, King J, Hunt L, Bogle S,
Baillod R, et al. Outcome in patients on continuous
ambulatory peritoneal dialysis and haemodialysis: 4-
year analysis of a prospective multicenter study. Lancet
1987; ii: 1105-9.
23. Nolph KD, Cutler SJ, Steinberg SM, Novak JW. Con-
tinuous ambulatory peritoneal dialysis in the United
States: A three year study. Kidney Intern 1985; 28:
198-205.
24. Charytan C, Spinowitz BS, Galler M. A Comparative
Study of Continuous Ambulatory Peritoneal Dialysis
and Center Hemodialysis. Efficacy, Complications, and
Outcome in the Treatment of End-Stage Renal Disease.
Arch Int Med 1986; 146: 1138-43.
25. Thomson NM, Agar JM, Atkins RC, Scott DF, Hum-
phrey TJ. Continuous Ambulatory Peritoneal Dialysis
(CAPD): An Established Treatment for Endstage Re-
nal Failure. Aust NZ J Med 1983; 13: 489-96.